Skip to content

A Study To Assess The Role Of Indicated Homoeopathic Medicine In Restoring Regular Menstrual Cycle In Cases Of PCOD

A Randomised Controlled Open Label Comparative Trial To Assess The Role Of Indicated Homoeopathic Medicine In Restoring Regular Menstrual Cycle In Cases Of PCOD - Not Applicable

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054082
Enrollment
50
Registered
2023-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E289- Ovarian dysfunction, unspecified

Interventions

Intervention1: Indicated Homoeopathic Medicine: Oral administration of Indicated Homoeopathic Medicine in lower potency 6C or 30C will be given in form of globules size 40, dose and repetition- BD or

Sponsors

Dr MPK Homoeopathic Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient giving consent for the study 2. Patient willing to have USG- whole abdomen with pelvic region before and after study 3. Amenorrhea of 3 months 4. PCOD with USG of Polycystic ovarian morphology seen on Ultrasound abdomen following Rotterdam diagnostic criteria

Exclusion criteria

Exclusion criteria: 1. Age group below 15 years and above 40 years 2. Diagnosed case of PCOD with scanty menses or profuse menses 3. Pregnant women and lactating women 4. Patient pursuing other treatment/ Hormone Replacement Therapy and are not willing to leave it 5. Severe systemic illness 6. History of Metformin or Oral Contraceptive Pills within 1 month of enrollment

Design outcomes

Primary

MeasureTime frame
Restoration of regular menstrual cycle for 3 consecutive months during the treatment duration of 7 monthsTimepoint: Restoration of regular menstrual cycle for 3 consecutive months during the treatment duration of 7 months

Secondary

MeasureTime frame
Post treatment changes in ovarian morphology as per Rotterdam Criteria as observed in USG pelvic regionTimepoint: 7 months

Countries

India

Contacts

Public ContactDr Sakshi Bhadana

Dr MPK Homoeopathic Medical College Hospital and Research Centre

drvanijasharma@gmail.com9680438770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026